Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar kendricklamar (61.73) Submitted: 11/20/2011 12:44:41 PM : Outperform Start Price: $2.35 SVNT Score: -73.34

jcode

Featured Broker Partners


Advertisement